Brolucizumab: Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe; Beovu® Page last updated: 20 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)